Baseline cognitive functions among elderly patients with localised breast cancer

被引:67
作者
Lange, Marie [1 ,2 ,3 ,4 ,5 ,6 ]
Giffard, Benedicte [1 ,2 ,3 ,4 ]
Noal, Sabine [6 ,11 ]
Rigal, Olivier [7 ,8 ]
Kurtz, Jean-Emmanuel [9 ]
Heutte, Natacha [5 ,6 ,10 ]
Levy, Christelle [11 ]
Allouache, Djelila [11 ]
Rieux, Chantal [6 ]
Le Fel, Johan [7 ]
Daireaux, Aurelie [6 ]
Clarisse, Benedicte [6 ]
Veyret, Corinne [8 ]
Barthelemy, Philippe [9 ]
Longato, Nadine [9 ]
Eustache, Francis [1 ,2 ,3 ,4 ]
Joly, Florence [2 ,5 ,6 ,12 ]
机构
[1] INSERM, U1077, Caen, France
[2] Normandie Univ, UMR S1077, Caen, France
[3] Ecole Prat Hautes Etud, UMR S1077, Caen, France
[4] CHU Caen, U1077, F-14000 Caen, France
[5] INSERM, U1086, Caen, France
[6] Ctr Francois Baclesse, Unite Rech Clin, F-14076 Caen 05, France
[7] Ctr Henri Becquerel, Serv Soins Support, F-76038 Rouen, France
[8] Ctr Henri Becquerel, Dept Oncol Med, F-76038 Rouen, France
[9] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France
[10] Univ Caen Basse Normandie, UFR Sci Pharmaceut, Caen, France
[11] Ctr Francois Baclesse, Comite Sein, F-14076 Caen 05, France
[12] CHU Caen, Serv Oncol, F-14000 Caen, France
关键词
Cognition disorders; Breast neoplasms; Ageing; Neuropsychology; Quality of life; MINI-MENTAL-STATE; CHEMOTHERAPY; POPULATION; CHEMOBRAIN; VALIDATION; NORMS; AGE;
D O I
10.1016/j.ejca.2014.05.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Cognitive deficits (CD) are reported among cancer patients receiving chemotherapy, but may also be observed before treatment. Though elderly patients are expected to be more prone to present age-related CD, poor information is available regarding the impact of cancer and chemotherapy on this population. This study assessed baseline cognitive functions (before adjuvant treatment) in elderly early stage breast cancer (EBC) patients. Methods: Women >65 years-old with newly diagnosed EBC were included in this prospective study. Episodic memory, working memory, executive functions and information processing speed were assessed by neuropsychological tests. Questionnaires were used to assess subjective CD, anxiety, depression, fatigue, quality of life and geriatric profile. Objective CD were defined using International Cognition and Cancer Task Force criteria. A group of elderly women without cancer coupled with published data related to healthy women were used for comparison (respectively to subjective and objective CD). Results: Among the 123 elderly EBC patients (70 4 years) included, 41% presented objective CD, which is greater than expected in healthy population norms (binomial test P<.0001). Verbal episodic memory was mainly impaired (21% of patients). No correlation was observed between objective CD and cancer stage or geriatric assessment. Subjective CD only correlated with verbal episodic memory (P=.01). Conclusions: This is the first large series assessing baseline cognitive functions in elderly EBC patients. More than 40% presented objective CD before any adjuvant therapy, which is higher than what is reported among younger patients. Our results reinforce the hypothesis that age is a risk factor for CD in EBC patients. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2181 / 2189
页数:9
相关论文
共 33 条
[1]   Candidate mechanisms for chemotherapy-induced cognitive changes [J].
Ahles, Tim A. ;
Saykin, Andrew J. .
NATURE REVIEWS CANCER, 2007, 7 (03) :192-201
[2]   Brain vulnerability to chemotherapy toxicities [J].
Ahles, Tim A. .
PSYCHO-ONCOLOGY, 2012, 21 (11) :1141-1148
[3]   Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science [J].
Ahles, Tim A. ;
Root, James C. ;
Ryan, Elizabeth L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) :3675-3686
[4]  
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
[5]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[6]   General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G) [J].
Brucker, PS ;
Yost, K ;
Cashy, J ;
Webster, K ;
Cella, D .
EVALUATION & THE HEALTH PROFESSIONS, 2005, 28 (02) :192-211
[7]  
CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207
[8]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]  
Clement JP, 1997, ENCEPHALE, V23, P91